Every day it seems we receive a new dismal piece of news regarding the COVID-19 pandemic. Good news isn’t hard to come by, however, if you keep up with the progress of various vaccines being developed around the world.
Although the process has been slow, the first COVID-19 vaccine tested in the United States is about to enter its final phase of testing on July 27. Results of the experimental vaccine, developed by the National Institutes of Health and Moderna, were released on Tuesday, and they’re certainly encouraging.
Of the first 45 volunteers who received the vaccine back in March, all of them developed neutralizing antibodies to COVID-19. Equally as important, the volunteers reported no serious side effects.
The results released Tuesday only included younger adults. The test was expanded to include dozens of older adults — the most at-risk group — but those results haven’t been made public yet.
The next stage of testing will include 30,000 volunteers, and will determine whether the inoculation is safe and effective by early 2021.